Oral contraceptive containing chlormadinone acetate and ethinylestradiol reduces plasma concentrations of matrix metalloproteinase-2 in women with polycystic ovary syndrome (2012)
- Authors:
- USP affiliated authors: FERRIANI, RUI ALBERTO - FMRP ; SANTOS, JOSE EDUARDO TANUS DOS - FMRP ; MACEDO, CAROLINA SALES VIEIRA - FMRP
- Unidade: FMRP
- DOI: 10.1111/j.1742-7843.2012.00895.x
- Subjects: DISPOSITIVOS ANTICONCEPCIONAIS FEMININOS; SÍNDROME DO OVÁRIO POLICÍSTICO (TRATAMENTO); METALOPROTEINASES
- Language: Inglês
- Imprenta:
- Publisher place: Chichester
- Date published: 2012
- Source:
- Título do periódico: Basic & Clinical Pharmacology & Toxicology
- ISSN: 1742-7835
- Volume/Número/Paginação/Ano: v. 111, n. 3, p. 211-216, 2012
- Este periódico é de assinatura
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: bronze
-
ABNT
GOMES, Valéria A. et al. Oral contraceptive containing chlormadinone acetate and ethinylestradiol reduces plasma concentrations of matrix metalloproteinase-2 in women with polycystic ovary syndrome. Basic & Clinical Pharmacology & Toxicology, v. 111, n. 3, p. 211-216, 2012Tradução . . Disponível em: https://doi.org/10.1111/j.1742-7843.2012.00895.x. Acesso em: 09 ago. 2024. -
APA
Gomes, V. A., Vieira, C. S., Jacob-Ferreira, A. L., Belo, V. A., Soares, G. M., França, J. B., et al. (2012). Oral contraceptive containing chlormadinone acetate and ethinylestradiol reduces plasma concentrations of matrix metalloproteinase-2 in women with polycystic ovary syndrome. Basic & Clinical Pharmacology & Toxicology, 111( 3), 211-216. doi:10.1111/j.1742-7843.2012.00895.x -
NLM
Gomes VA, Vieira CS, Jacob-Ferreira AL, Belo VA, Soares GM, França JB, Ferriani RA, Tanus-Santos JE. Oral contraceptive containing chlormadinone acetate and ethinylestradiol reduces plasma concentrations of matrix metalloproteinase-2 in women with polycystic ovary syndrome [Internet]. Basic & Clinical Pharmacology & Toxicology. 2012 ; 111( 3): 211-216.[citado 2024 ago. 09 ] Available from: https://doi.org/10.1111/j.1742-7843.2012.00895.x -
Vancouver
Gomes VA, Vieira CS, Jacob-Ferreira AL, Belo VA, Soares GM, França JB, Ferriani RA, Tanus-Santos JE. Oral contraceptive containing chlormadinone acetate and ethinylestradiol reduces plasma concentrations of matrix metalloproteinase-2 in women with polycystic ovary syndrome [Internet]. Basic & Clinical Pharmacology & Toxicology. 2012 ; 111( 3): 211-216.[citado 2024 ago. 09 ] Available from: https://doi.org/10.1111/j.1742-7843.2012.00895.x - Contracepção na adolescência
- Ultrasonographic and laboratory markers of metabolic and cardiovascular disease risk in obese women with polycystic ovary syndrome
- Oral anticoagulant therapy does not modify the bleeding pattern associated with the levonorgestrel-releasing intrauterine system in women with thrombophilia and/or a history of thrombosis
- Effects of two contraceptives containing drospirenone on blood pressure in normotensive women: a randomized-controlled trial
- Effect of the levonorgestrel releasing intrauterine system on cardiovascular risk markers among women with thrombophilia or previous venous thromboembolism
- Local anaesthetic in uterine cervix is not associated with lower pain score in levonorgestrel-releasing intrauterine system insertion in women without previous vaginal delivery
- Satisfaction score and metabolic effects of the use of levonorgestrel-releasing intrauterine system in nonobese women with polycystic ovary syndrome
- Imbalanced circulating matrix metalloproteinases in polycystic ovary syndrome
- Timing of etonogestrel-releasing implants and growth of breastfed infants: a randomized controlled trial
- Body composition characteristics predict sexual functioning in obese women with or without PCOS
Informações sobre o DOI: 10.1111/j.1742-7843.2012.00895.x (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
